Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Paragon 28 Inc (NY: FNA )

12.91 -0.14 (-1.07%)
Official Closing Price Updated: 7:00 PM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 276,923
Open 13.11
Bid (Size) 12.19 (1)
Ask (Size) 13.28 (1)
Prev. Close 13.05
Today's Range 12.77 - 13.13
52wk Range 12.45 - 21.49
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Paragon 28®, Inc. Receives FDA Approval for IDE Feasibility Study of Its SMART Total Talus™ System for use in Conjunction with the APEX 3D™ Total Ankle Replacement System
From Paragon 28, Inc.
Via Business Wire
Paragon 28 to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
From Paragon 28, Inc.
Via Business Wire

Performance

YTD
-32.66%
-32.66%
1 Month
+0.08%
+0.08%
3 Month
-28.12%
-28.12%
6 Month
-22.56%
-22.56%
1 Year
-28.44%
-28.44%

More News

Read More
Paragon 28 Reports Second Quarter 2023 Financial Results and Reaffirms 2023 Net Revenue Guidance
From Paragon 28, Inc.
Via Business Wire
Preview: Paragon 28's Earnings
Via Benzinga
Paragon 28 to Present at the Canaccord Genuity 43rd Annual Growth Conference
From Paragon 28, Inc.
Via Business Wire
Paragon 28: Q1 Earnings Insights
Via Benzinga
Looking Into Paragon 28's Return On Capital Employed
Via Benzinga
Paragon 28 To Report Second Quarter Financial Results on August 2, 2023
From Paragon 28, Inc.
Via Business Wire
Paragon 28 Launches Comprehensive Supramalleolar Osteotomy System
From Paragon 28, Inc.
Via Business Wire
Paragon 28 Reports First Quarter 2023 Financial Results and Reaffirms 2023 Net Revenue Guidance
From Paragon 28, Inc.
Via Business Wire
Paragon 28 to Present at the Bank of America Securities 2023 Healthcare Conference
From Paragon 28, Inc.
Via Business Wire
Paragon 28 Launches Phantom® Metatarsal Shortening System
From Paragon 28, Inc.
Via Business Wire
Paragon 28 To Report First Quarter Financial Results on May 4, 2023
From Paragon 28, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 11, 2023
Via Benzinga
Paragon 28 Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Financial Guidance
From Paragon 28, Inc.
Via Business Wire
Paragon 28 to Present at Upcoming Investor Conferences
From Paragon 28, Inc.
Via Business Wire
Paragon 28, Inc. Announces Closing of Underwriters’ Option to Purchase Additional Shares in Connection with Public Offering of Common Stock
From Paragon 28, Inc.
Via Business Wire
Paragon 28 To Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023
From Paragon 28, Inc.
Via Business Wire
7 Undiscovered Stocks to Watch for the Next Big Thing
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Panbela Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Paragon 28, Inc. Announces Pricing of Public Offering
From Paragon 28, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Paragon 28, Inc. Announces Proposed Public Offering of Common Stock
From Paragon 28, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.